课题基金 / 基金详情

A Novel Cell Death Pathway Induced by Galectin-1

A Novel Cell Death Pathway Induced by Galectin-1
Galectin-1 诱导的新型细胞死亡途径
批准号:
6753612
负责人:
Linda G Baum
金额:
$25.86万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-01 至 2005-05-31

项目摘要

项目成果

Linda G Baum的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Cell death is a critical regulatory process in development, in homeostasis, and in disease. Many cell death triggers have been identified, although little is known about many of the molecular pathways that lead to cell death. Galectin-1, a member of a family of evolutionarily ancient lectins, induces death of thymocytes and T-cells. In mammals, galectin-1 is expressed in lymphoid tissues, at sites of inflammation, and in some types of cancer. Galectin-1 has also been shown to be immunosuppressive in several animal models of autoimmune disease. Galectin-1 induces cell death of transformed epithelial cells as well, so that galectin-1 mediated cell death may be a fundamental mechanism that regulates cell survival in many tissues. Other galectin family members have pro- or anti-apoptotic activities in different tissues, suggesting that different galectins may cooperate to regulate cell death. The goal of this application is to characterize the molecular mechanism of galectin-1 cell death, to understand the interaction of galectin-1 with glycoprotein receptors on the cell surface, and the downstream events that regulate cell death. The Specific Aims are: 1. To define features of the T-cell surface receptors for galectin-l required to transmit the death signal. CD7 and CD43 are glycoprotein receptors for galectin-1. Features of the glycans and the polypeptides that are essential for sending the death signal will be identified. 2. To examine how galectin-l binding to T-cells results in molecular interactions to deliver the death signal. Galectin-1 binding results in a unique pattern of receptor reorganization on the T-cell surface. We will identify features of the receptors required for this interaction, and investigate whether receptor reorganization is required for cell death. Effects of galectin-1 on cytoskeletal linker proteins and on the actin cytoskeleton will be characterized. To examine cell-cell interactions that govern T-cell death, receptor reorganization during galectin-1 mediated binding of T-cells to thymic stromal cells will be examined. 3. To characterize intracellular components that regulate the galectin-l cell death pathway. We will examine the roles of the protein kinase C and protein phosphatase families of enzymes in regulating galectin1 cell death. We determine how galectin-3 expression regulates T-cell susceptibility to galectin-1.
期刊论文(16)
专著(0)
科研奖励(0)
会议论文
New roles for galectins in brain tumors--from prognostic markers to therapeutic targets.
半乳糖凝集素在脑肿瘤中的新作用——从预后标志物到治疗靶点。
DOI: 10.1111/j.1750-3639.2005.tb00507.x
发表时间: 2005
期刊: Brain pathology (Zurich, Switzerland)
影响因子: --
作者: [Stillman,BriannaN, Mischel,PaulS, Baum,LindaG]
通讯作者: Baum,LindaG
CD45-mediated fodrin cleavage during galectin-1 T cell death promotes phagocytic clearance of dying cells.
半乳糖凝集素 1 T 细胞死亡过程中 CD45 介导的胞因子裂解促进垂死细胞的吞噬清除。
DOI: 10.4049/jimmunol.0804329
发表时间: 2009
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Pang,Mabel, He,Jiale, Johnson,Pauline, Baum,LindaG]
通讯作者: Baum,LindaG
Preparation of recombinant human galectin-1 and use in T-cell death assays.
重组人半乳糖凝集素-1 的制备及其在 T 细胞死亡测定中的应用。
DOI: 10.1016/s0076-6879(03)01075-9
发表时间: 2003
期刊: Methods in enzymology.
影响因子: --
作者: [Pace,KarenE, Hahn,HejinP, Baum,LindaG]
通讯作者: Baum,LindaG
Regulation of inflammatory cell migration in asthma
Regulation of inflammatory cell migration in asthma
Overcoming tumor cell resistance to apoptosis with a natural product, GCS-100
Overcoming tumor cell resistance to apoptosis with a natural product, GCS-100
海外基金